B-Cell Malignancies: The Impact of Biomarkers on Treatment Decisions

Activity: Participating in or organising an eventConference participation


On May 10th 2013, the University of York’s Epidemiology & Cancer Statistics Group, in its role as major founding partner of the Haematological Malignancy Research Network (www.hmrn.org), successfully hosted the B-cell malignancies: the impact of biomarkers on treatment decisions single-day conference. The event was held at the National Science Learning Centre and organised in association with the Lunenburg Lymphoma Biomarker Consortium, an international initiative studying the application of biomarker analyses to clinical practice in lymphoma. The event was part-funded by the Wellcome Trust (Centre for Chronic Diseases and Disorders – ref: 097829/Z/11/A) and Roche.
Period10 May 2013
Event typeConference
LocationYork , United KingdomShow on map